BIO-RAD LABORATORIES INC.

Company Snapshot

Founded: 1952
Entity Type: Public
Employees: 7,450
Region: U.S.
Revenue: $2,583.2 Millions
Revenue Year: 2025
Segment: Life Sciences and Clinical Diagnostics
Headquarter: California, U.S.
Key Geographics: U.S., Europe, Asia, Canada, Latin America
Corporate Address: 1000 Alfred Nobel Drive, Hercules, California, 94547 U.S. Tel. +1-510-724-7000 www.bio-rad.com

Company Overview

Bio-Rad Laboratories develops biochemical and radiochemical products. It designs and manufactures a range of diagnostic tools and services for research institutions, hospitals, pharmaceutical and biotechnology companies, and academic institutions. It operates in two business segments: life science and clinical diagnostics. The life sciences category's equipment, systems, reagents, and consumables are used to characterize, quantify, segregate, and purify biological components such as proteins, cells, and nucleic acids.

Bio-Rad's technologies find applications in analyzing biomolecules (antibodies, proteins, nucleic acids, cells, bacteria). Technologies include electrophoresis, imaging, multiplex immunoassay, chromatography, microbiology, protein function analysis, transfection, flow cytometry, cell sorting, amplification and real-time and digital PCR.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

BIO-RAD LABORATORIES INC. In Reports

Global Gene Transfer Technologies Market

Analyze the global gene transfer technologies market, covering viral and non-viral methods, applications in gene therapy, and growth forecasts to 2030.

Liquid Biopsy with Emphasis on Cancer: Global Markets

Analyse the global liquid biopsy market in cancer by indication, technology, biomarker, and application, with regional forecasts and competitive insights to 2031.

The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

BCC Research detailed report on US Biodefense-Related Rapid Pathogen Identification and Treatments Market revenue for the base year 2024 and estimated data for the forecast period 2025 through 2030.

Company's Business Segments

  • Life Sciences : It offers instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids
  • Clinical Diagnostics : It includes diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories
  • Others : Miscellaneous operations

Applications/End User Industries

  • Academic and Research Institutions
  • Universities
  • Research Centers
  • Academic Laboratories
  • Biotechnology
  • Blood Banks and Transfusion Centers
  • Regulatory Agencies
  • Public Health Organizations
  • Contract Research Organizations
  • Clinical Laboratories
  • Medical Laboratories
  • Diagnostic Centers
  • Physician Office Laboratories
  • Pharmaceuticals
AI Sentiment